Skip to main content
. 2021 Mar 11;13(3):904. doi: 10.3390/nu13030904

Figure 7.

Figure 7

Effect of chronic oral administration of Safr’InsideTM (6.25 mg/Kg) on gene expression of markers of serotonin and dopamine systems. Relative expression in: (a) the Frontal Cortex (FCx); (b) the Striatum (Str) and (c) the Hippocampus (HPC). Data are represented as the foldchange calculated relative to the control group (baseline = 1). Results are shown as mean ± SEM. Control (Water): n = 7–8; Safr’Inside: n = 8–9. # p = 0.05, * p < 0.05.